Moreover, MMP2, MMP9, MMP12, and MMP16-enriched KEGG pathways include “Bladder cancer, endocrine resistance, and relaxin signaling pathway”, etc., (Fig. 8D). This evidence concerns the gene MMP12 and urinary bladder cancer.